Bepotastine is a second-generation H1 antihistamine offering rapid relief of allergic rhinitis and conjunctivitis symptoms with minimal sedation. Simson Pharma's Bepotastine reference standard and impurities support stability-indicating method development for this allergy-focused therapeutic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bepotastine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.